CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later) 		 
     
 
 
 
Dawnrays Pharmaceutical (Holdings) Ltd Company Snapshot
Business Description:
Dawnrays Pharmaceutical (Holdings) Ltd operates in the Pharmaceutical preparations sector. Dawnrays Pharmaceutical (Holdings) Ltd is an investment holding company. The Company, through its subsidiaries, is principally engaged in the development, manufacture and sale of non-patented pharmaceutical medicines, including intermediate pharmaceutical, bulk medicines and finished drugs. It operates in two segments: intermediates and bulk medicines, and finished drugs. Intermediates and bulk medicines include all the Company's chemical and pharmaceutical intermediates and bulk medicines. Finished drugs include all its antibiotic and non-antibiotic finished preparations with dosage forms of powder for injection and solid-dosage-form etc. During the year ended December 31, 2010, the Company obtained three production permits for Lansoproazole Tablets, Entecavir Bulk Medicines and Dispersible Tablets from the State Food and Drug Administration, received 28 supplemental production permits for 16 products, 82 re-registered production permits for 37 products and one clinical permit. In our complete report available for purchase the company is compared to: Hua Han Bio-Pharmaceutical Holdings Ltd, China Shineway Pharmaceutical Group Limited and Jiwa Bio-Pharm Holdings Ltd.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Dawnrays Pharmaceutical (Holdings) Ltd
  Stock Performance Chart for Dawnrays Pharmaceutical (Holdings) Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (2/3/2012): 2.20
(Figures in Hong Kong Dollars)
1 Week 1.4%   13 Weeks -4.3%  
4 Weeks -3.5%   52 Weeks -36.0%  
 
Dawnrays Pharmaceutical (Holdings) Ltd Key Data:
  Ticker: 2348 Country: HONG KONG
  Exchanges: HKG Major Industry: Drugs, Cosmetics & Health Care
    Sub Industry: Ethical Drug Manufacturers
  2010 Sales 1,478,900,573
(Year Ending Jan 2011).		 Employees: 1,527
  Currency: Hong Kong Dollars Market Cap: 1,756,224,800
  Fiscal Yr Ends: December Shares Outstanding: 798,284,000
  Share Type: Ordinary Closely Held Shares: 478,684,000
 
 
Featured Products and Services
  
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.